Elbe Klinikum Buxtehude

Buxtehude, Lower Saxony 21614

0 studies enrolling now · 5 studies all time

What they study most

Atopic Dermatitis, Chronic Inducible Urticaria, Psoriasis

Studies at this site

• A Study of CDX-0159 in Patients With Chronic Inducible Urticaria — Completed
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis — Completed
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early
• Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. — Completed